Clinical trial

Tumour Necrosis Factor Release in Locally Advanced Breast Cancer Patients Receiving Neoadjuvant Docetaxel

NCT01539876

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

PROCEDURE · Unmapped registry intervention Fine needle aspiration assessing tumour TNFa levels Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Tumour Necrosis Factor Release in Locally Advanced Breast Cancer Patients Receiving Neoadjuvant Docetaxel

Design: INTERVENTIONAL · Status: WITHDRAWN · Phase: PHASE1

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusWITHDRAWN

Study typeINTERVENTIONAL

Start dateUnknown

PhasePHASE1

Conditions

Breast Cancerverified · MONDO: breast cancer

Interventions

Fine needle aspiration assessing tumour TNFa levelsPROCEDURE

Sponsors & collaborators

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'slead sponsor

Mapped research locations

LondonOntario, Canada1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01539876 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.